ProBiora Health is bringing the science of probiotics to oral care by developing and marketing a complete line of proprietary probiotics that are specifically designed to enhance oral health for humans and pets. Our products are developed from ProBiora3®, which was discovered by Dr. Jeffrey Hillman on the concept of replacement therapy.

ProBiora3® is a blend of three naturally occurring strains of beneficial bacteria, including Streptococcus oralis KJ3®, Streptococcus uberis KJ2® and Streptococcus rattus JH145®, which support overall oral health. We believe ProBiora3® is the most comprehensive oral care probiotics technology currently available in the oral healthcare market.

Starting in 2008, a line of consumer, professional and pet oral products based on Dr. Hillman’s discovery was introduced under the Evora brand name. In 2009, both the EvoraPlus and the EvoraPet product lines were introduced to the consumer market. And in 2010, EvoraPro was introduced to the professional dental care market.

In June 2016, the complete line of Evora (ProBiora) consumer, professional and pet products were purchased by ProBiora Health™, which is led by Christine Koski, a former Oragenics board member and longtime investor.

Dental

Health Care

ProBiora Health LLC

ProBiora Health LLC's headquarters in Tampa, FL, United States

Description

People

Jobs